Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “COVID-19”

Validation of Biomarkers for Long COVID in the LIINC Viral Immunopathogenesis and Persistence Repeat Donor Cohort (VIPER)Recruiting
NCT07770022N/AUpdated Aug 18, 2026
Sponsor: University of California, San Francisco
Long Covid
United States
Sonlicromanol in Post-COVIDRecruiting
NCT07298005Phase 2Updated Aug 18, 2026
Sponsor: Michele van Vugt
Post COVID Condition
Netherlands
Micro-choice-based Intervention for Multicausal FatigueRecruiting
NCT07726082NAUpdated Aug 18, 2026
Sponsor: University Hospital, Basel, Switzerland
Multicausal Fatigue · Fatigue · Post COVID Condition · Long COVID Syndrome
Switzerland
Respiratory Virus Sampling and RepositoryRecruiting
NCT05266222N/AUpdated Aug 17, 2026
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Influenza · COVID-19
United States
A Study to Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19Terminated
NCT05386472Phase 1Updated Aug 17, 2026
Sponsor: Pfizer
COVID-19
United States
Psychosomatic, Physical Activity or Both for Post-covid19 SyndromCompleted
NCT06042751NAUpdated Aug 17, 2026
Sponsor: Hannover Medical School
Post-COVID-19 Syndrome
Germany
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe DiseaseRecruiting
NCT06679140Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
COVID-19 SARS-CoV-2 Infection
United States, Argentina, Belgium, Brazil, Bulgaria +14 more
Study of Flonoltinib Maleate Tablets in the Treatment of Severe Novel Coronavirus (COVID-19) InfectionTerminated
NCT05713279NAUpdated Aug 14, 2026
Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd
COVID-19
China
Evaluating the Use of Patient Navigation to Promote Timely Diagnostic Evaluation During the COVID-19 PandemicCompleted
NCT05181722NAUpdated Aug 14, 2026
Sponsor: Johns Hopkins University
Breast Cancer
United States
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)Recruiting
NCT06667700Phase 3Updated Aug 14, 2026
Sponsor: Merck Sharp & Dohme LLC
Coronavirus Disease (COVID-19)
United States, Argentina, Brazil, Bulgaria, Colombia +19 more
ME/CFS Brain Fog: Cognitive Rehabilitation TrialRecruiting
NCT07523113NAUpdated Aug 14, 2026
Sponsor: University of Alabama at Birmingham
ME/CFS · ME/CFS Following EBV-associated Infectious Mononucleosis · ME/CFS Following COVID-19 · Chronic Fatigue
United States
Five-year Follow-up After Sars-CoV-2 Infection: Prevalence and Evolution of Post-acute Sequalae of COVID-19 (PASC)Not Yet Recruiting
NCT07766512N/AUpdated Aug 14, 2026
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Long COVID · COVID-19 · Post-Acute COVID-19 Syndrome · Post-Acute COVID-19 Infection
Brain-Training Treatment for Long COVID in Older AdultsCompleted
NCT05705193NAUpdated Aug 14, 2026
Sponsor: UConn Health
Post-Acute COVID-19 Syndrome
United States
Expressive Writing for the Management of Stress in Cancer SurvivorsRecruiting
NCT04776941NAUpdated Aug 14, 2026
Sponsor: M.D. Anderson Cancer Center
Hematopoietic and Lymphoid Cell Neoplasm · Malignant Solid Neoplasm
United States
A Study to Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults Aged 60 and Older Living in Korean Long-term Care Hospitals Who Have COVID-19Completed
NCT07089680N/AUpdated Aug 14, 2026
Sponsor: Pfizer
Coronavirus Disease 2019 (COVID-19)
South Korea
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely ImmunocompromisedRecruiting
NCT07013474Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
COVID-19 Infection
United States, Argentina, Belgium, Brazil, Denmark +13 more
Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.Terminated
NCT05785390Phase 2Updated Aug 13, 2026
Sponsor: Novatek Pharmaceuticals
COVID-19
United States
Remote Methadone Ingestion Surveillance Trial (RMIST)Completed
NCT05259501NAUpdated Aug 13, 2026
Sponsor: University of Texas Southwestern Medical Center
Opioid Use Disorder
United States
Taurine Supplementation in Adolescents With Post-COVID ConditionNot Yet Recruiting
NCT07682402Phase 1, Phase 2Updated Aug 13, 2026
Sponsor: University of Alberta
Long COVID · Post COVID-19 Condition · PASC Post Acute Sequelae of COVID 19
Outpatient Treatment With Anti-Coronavirus ImmunoglobulinTerminated
NCT04910269Phase 3Updated Aug 13, 2026
Sponsor: University of Minnesota
COVID · SARS-CoV2 Infection · Covid19
United States, Argentina, Australia, Denmark, Greece +8 more
A Longitudinal Study of COVID-19 Sequelae and ImmunityActive Not Recruiting
NCT04411147N/AUpdated Aug 13, 2026
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
COVID-19
United States
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19Terminated
NCT05530317NAUpdated Aug 13, 2026
Sponsor: University of California, San Francisco
Long COVID · COVID-19
United States
Taurine Supplementation in Long COVIDRecruiting
NCT06721949Phase 2, Phase 3Updated Aug 13, 2026
Sponsor: University of Alberta
Long COVID
Canada
Description of the Lived Experiences of Family Caregivers for People With Mental Health ComorbiditiesCompleted
NCT07760701N/AUpdated Aug 12, 2026
Sponsor: Centre for Infectious Disease Research in Zambia
Depression · Anxiety · Trauma
Zambia
Cross-Sectional Evaluation of Persistence of SARS-CoV-2 Remnants After Recovery From Acute InfectionRecruiting
NCT06577467N/AUpdated Aug 12, 2026
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
PASC Post Acute Sequelae of COVID-19
United States

Previous page Next page